可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]王瑶,陶则伟,陆贤,等. B型钠尿肽的研究进展[J]. 心脏杂志,2003,15(6):555-557.
[2]Morita E,Yasue H,Yoshimura M,et al. Increased plasma level of BNP in patients with AMI[J]. J Am Coll Cardiol,1993,88:82-91.
[3]Talwar S,Squire IB, Downie PF,et al. Profile of plasma Nterminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction[J]. Eur Heart J,2000,21(18): 1514-1521.
[4]Richards AM,Nicholls MG,Yandle TG,et al. Plasma NTproBNP and adrenomedulin.New neurohormonal predictors of left ventricular dysfunction and prognosis after myocardial infarction[J]. Circulation,1998,97:1921-1929.
[5]Sabatine MS. Multimarker approach to risk stratification in nonST elevation acute coronary syndromes: simultaneous assessment of troponin I, Creactive protein, and Btype natriuretic peptide[J]. Circulation,2002,105(15): 1760-1763.
[6]Omland T, Persson A, Ng L, et al. Nterminal proBtype natriuretic peptide and longterm mortality in acute coronary syndromes[J]. Circulation,2002,106: 2913-2918.